← Leaderboards
David Feola
University Of Kentucky
$2,091,332
Attributed
$2,489,811
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $542.1K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,489,811 · 4
By mechanism
R01$1,788,733 · 1
R61$542,094 · 1
R03$148,416 · 1
M01$10,568 · 1
Top collaborators
- Ahmed Abdel-Latif1 shared
- Brian S Murphy1 shared
- Vincent Joseph Venditto1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Subbarao Bondada$10,589,346
- Frederick Schmitt$9,256,885
- John C Gensel$6,176,566
- Diane Ruth Follingstad$1,230,175
- Samirkumar Patel$2,587,791
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsLeadT-LymphocyteImmuneNeutrophilPhenotypeFutureAffectInflammationInflammatory ResponseInflammatoryAnimalsMouse ModelImmune ResponseMacrophageAirway InflammationIn VitroAcuteMacrophage ActivationCharacteristicsChronicLungInfection
Grant awards (9)
Liposomal azithromycin to treat cardiac inflammation$542,094
R61 · FY2025 · HL
Alternative macrophage activation in acute Pseudomonas pneumonia$360,315
R01 · FY2016 · AI · contact PI
Alternative macrophage activation in acute Pseudomonas pneumonia$361,308
R01 · FY2015 · AI · contact PI
Alternative macrophage activation in acute Pseudomonas pneumonia$362,213
R01 · FY2014 · AI · contact PI
Alternative macrophage activation in acute Pseudomonas pneumonia$341,252
R01 · FY2013 · AI · contact PI
Alternative macrophage activation in acute Pseudomonas pneumonia$363,645
R01 · FY2012 · AI · contact PI
Pneumocystis jirovecii and macrophages in COPD$74,250
R03 · FY2010 · HL · contact PI
Pneumocystis jirovecii and macrophages in COPD$74,166
R03 · FY2009 · HL
IMMUNOTOXICITY OF ZIDOVUDINE PLUE SULFAMETHOXAZOLE-TRIMETHOPRIM EXPOSURE$10,568
M01 · FY2007 · RR · contact PI